World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
10533
World Ranking
3809
National Ranking
335

Overview

John Wood is affiliated with the National Institute for Biological Standards and Control in the United Kingdom. Their research contributions span multiple fields within medicine and health professions, with a notable focus on surgery, physiology, speech and hearing, pulmonary and respiratory medicine, and pathology and forensic medicine.

The main topics addressed in their research include:

  • Dysphagia Assessment and Management
  • Tracheal and airway disorders
  • Salivary Gland Tumors Diagnosis and Treatment
  • Tumors and Oncological Cases
  • Head and Neck Anomalies
  • Obstructive Sleep Apnea Research
  • Voice and Speech Disorders

John Wood has published articles primarily in the following venues:

  • International Journal of Pediatric Otorhinolaryngology
  • Clinical Otolaryngology

Selected recent papers include:

  • Juvenile recurrent parotitis: Review and proposed management algorithm, 2021, International Journal of Pediatric Otorhinolaryngology
  • BiZact ™ tonsillectomy: Predictive factors for post-tonsillectomy haemorrhage from a 1717 case series, 2023, Clinical Otolaryngology
  • Poor correlation between airway fluoroscopy and rigid bronchoscopic evaluation in paediatric tracheomalacia, 2022, International Journal of Pediatric Otorhinolaryngology

Frequent co-authors collaborating with John Wood include:

  • Charmaine M. Woods
  • Ed Toll
  • Francis Hall
  • Murali Mahadevan
  • Boyuan Mao

Best Publications

  • Influenza

    Unknown

  • Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine : a randomised trial of two potential vaccines against H5N1 influenza

    Karl G Nicholson;Anthony E Colegate;Audino Podda;Iain Stephenson

  • Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

    Jean-Louis Bresson;Christian Perronne;Odile Launay;Catherine Gerdil

  • Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy

    Iain Stephenson;Iain Stephenson;Roberto Bugarini;Karl G. Nicholson;Audino Podda

  • An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines.

    J.M. Wood;G.C. Schild;R.W. Newman;Valerie Seagroatt

  • Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

    Jiangtao Lin;Jiansan Zhang;Xiaoping Dong;Hanhua Fang

  • Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature.

    W J Bean;Y Kawaoka;J M Wood;J E Pearson

  • Confronting the avian influenza threat: vaccine development for a potential pandemic

    Iain Stephenson;Iain Stephenson;Karl G Nicholson;John M Wood;Maria C Zambon

  • Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

    Iain Stephenson;Karl G Nicholson;Anthony Colegate;Audino Podda

  • Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

    Carolyn Nicolson;Diane Major;John M. Wood;James S. Robertson

  • Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America.

    V. S. Hinshaw;J. M. Wood;R. G. Webster;R. Deibel

  • Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

    I Stephenson;J.M Wood;K.G Nicholson;A Charlett

  • Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin

    I. Stephenson;J.M. Wood;K.G. Nicholson;M.C. Zambon

  • Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.

    Iain Stephenson;Karl G Nicholson;Reinhardt Glück;Robert Mischler

  • From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

    John M. Wood;James S. Robertson

  • Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season

    Ian G Barr;John McCauley;Nancy Cox;Rod Daniels

  • Reproducibility of Serologic Assays for Influenza Virus A (H5N1)

    Iain Stephenson;Alan Heath;Diane Major;Robert W. Newman

  • The next influenza pandemic: lessons from Hong Kong, 1997.

    René Snacken;Alan P. Kendal;Lars Reinhardt Haaheim;John M. Wood

  • An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination

    Rebecca J. Cox;Karl A. Brokstad;Mark A. Zuckerman;John M. Wood

  • A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.

    Rebecca J. Cox;Abdullah S. Madhun;Solveig Hauge;Haakon Sjursen

  • Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study.

    Iain Stephenson;Rose Gaines Das;John M. Wood;Jacqueline M. Katz

Frequent Co-Authors

Maria Zambon
Maria Zambon Public Health England
Jacqueline M. Katz
Jacqueline M. Katz Emory University
Karl G. Nicholson
Karl G. Nicholson University of Leicester
Robert G. Webster
Robert G. Webster St. Jude Children's Research Hospital
Yoshihiro Kawaoka
Yoshihiro Kawaoka University of Tokyo
Philip D. Minor
Philip D. Minor National Institute for Biological Standards and Control
Nancy J. Cox
Nancy J. Cox Vanderbilt University Medical Center
Masato Tashiro
Masato Tashiro Nagasaki University
Alan J. Hay
Alan J. Hay Medical Research Council
Jon Nicholl
Jon Nicholl University of Sheffield

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens doors to various career pathways, especially in healthcare and research. For those looking to integrate clinical practice with immunological expertise, accelerated nursing programs offer efficient routes. Many students opt for accelerated FNP programs, which prepare nurses to become Family Nurse Practitioners through fast-tracked online coursework.

If you're starting without a nursing background, online RN programs are an accessible option. Specialized online RN programs for non nurses provide a pathway to obtain registered nurse credentials, allowing you to work closely with immunology in clinical settings.

For those seeking quicker entry into nursing roles, there are easiest accelerated nursing programs designed to minimize barriers and expedite degree completion without compromising quality. Similarly, easiest LPN programs to get into provide accessible options for Licensed Practical Nurses to enter the workforce swiftly and engage in immunology-related clinical care.

Choosing the right program depends on your current qualifications and career goals. These online pathways ensure that individuals can pursue immunology-linked professions with flexible options tailored to different educational backgrounds.

Best Scientists Citing John Wood

Trending Scientists

Recently Published Articles